Genoray Statistics

Total Valuation

Genoray has a market cap or net worth of KRW 76.40 billion. The enterprise value is 87.36 billion.

Market Cap	76.40B
Enterprise Value	87.36B

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Genoray has 13.40 million shares outstanding. The number of shares has decreased by -1.72% in one year.

Current Share Class	n/a
Shares Outstanding	13.40M
Shares Change (YoY)	-1.72%
Shares Change (QoQ)	+1.03%
Owned by Insiders (%)	29.19%
Owned by Institutions (%)	1.13%
Float	9.38M

Valuation Ratios

The trailing PE ratio is 7.59.

PE Ratio	7.59
Forward PE	n/a
PS Ratio	0.72
PB Ratio	0.80
P/TBV Ratio	n/a
P/FCF Ratio	16.25
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.65, with an EV/FCF ratio of 18.58.

EV / Earnings	8.53
EV / Sales	0.81
EV / EBITDA	4.65
EV / EBIT	6.71
EV / FCF	18.58

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.27.

Current Ratio	2.55
Quick Ratio	0.87
Debt / Equity	0.27
Debt / EBITDA	1.39
Debt / FCF	5.54
Interest Coverage	15.63

Financial Efficiency

Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 7.24%.

Return on Equity (ROE)	10.95%
Return on Assets (ROA)	6.63%
Return on Capital (ROIC)	7.24%
Revenue Per Employee	329.56M
Profits Per Employee	31.14M
Employee Count	329
Asset Turnover	0.88
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.16%
50-Day Moving Average	6,018.40
200-Day Moving Average	6,352.45
Relative Strength Index (RSI)	32.97
Average Volume (20 Days)	15,121

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genoray had revenue of KRW 108.42 billion and earned 10.24 billion in profits. Earnings per share was 751.40.

Revenue	108.42B
Gross Profit	41.08B
Operating Income	13.02B
Pretax Income	10.47B
Net Income	10.24B
EBITDA	18.77B
EBIT	13.02B
Earnings Per Share (EPS)	751.40

Full Income Statement

Balance Sheet

The company has 15.11 billion in cash and 26.04 billion in debt, giving a net cash position of -10.94 billion or -815.94 per share.

Cash & Cash Equivalents	15.11B
Total Debt	26.04B
Net Cash	-10.94B
Net Cash Per Share	-815.94
Equity (Book Value)	95.62B
Book Value Per Share	7,090.85
Working Capital	46.00B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.98 billion and capital expenditures -2.27 billion, giving a free cash flow of 4.70 billion.

Operating Cash Flow	6.98B
Capital Expenditures	-2.27B
Free Cash Flow	4.70B
FCF Per Share	350.84

Full Cash Flow Statement

Margins

Gross margin is 37.89%, with operating and profit margins of 12.01% and 9.45%.

Gross Margin	37.89%
Operating Margin	12.01%
Pretax Margin	9.65%
Profit Margin	9.45%
EBITDA Margin	17.31%
EBIT Margin	12.01%
FCF Margin	4.34%

Dividends & Yields

This stock pays an annual dividend of 160.00, which amounts to a dividend yield of 2.81%.

Dividend Per Share	160.00
Dividend Yield	2.81%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	21.33%
Buyback Yield	1.72%
Shareholder Yield	4.52%
Earnings Yield	13.18%
FCF Yield	6.16%

Dividend Details

Stock Splits

The last stock split was on February 21, 2020. It was a forward split with a ratio of 3.

Last Split Date	Feb 21, 2020
Split Type	Forward
Split Ratio	3

Scores

Genoray has an Altman Z-Score of 3.85.

Altman Z-Score	3.85
Piotroski F-Score	n/a